A bstract
Studies have questioned whether renal dysfunction in sickle cell disease is linked to hemolysis-associated vasculopathy. We have investigated renal function and markers of hemolysis in a cohort of 424 adult African-British patients with sickle cell disease. While significant associations were found in HbSS and HbSβ 0 (sickle cell anemia) patients with and without controlling for covariates between haemolytic markers and albuminuria, the associations were not significant in patients with HbSC. Estimated glomerular filtration rate, a marker of renal function, correlated significantly with reticulocyte count and bilirubin.
Introduction
Sickle cell nephropathy (SCN) is a highly prevalent and potentially life-threatening complication of sickle cell anaemia (SCA). End-stage renal failure is present in around 11%
of patients with SCA, and this increases markedly with age. [1] [2] As life expectancy continues to improve in patients with SCA, 3 we can expect the proportion of those suffering from chronic organ damage, such as SCN, to increase. 2 Hyperfiltration and hyposthenuria (inability to concentrate urine appropriately) are the earliest manifestations of SCN. 4 It is thought that chronic ischaemia secondary to repeated vaso-occlusive events in the microvasculature of the renal medulla results in a prostaglandin-induced increase in total renal plasma flow leading to the raised glomerular filtration rate (GFR) seen in childhood and early adulthood. [4] [5] Prolonged hyperfiltration eventually leads to glomerular sclerosis and the GFR decreases towards normal as the patient ages. 4 In some this decline is accelerated and continuous resulting in end-stage renal failure. 6 The glomerular injury often also results in proteinuria, which may be severe enough to cause nephrotic syndrome in some patients. 4 Microalbuminuria is an early manifestation of proteinuria in SCN and other non-sickle nephropathies; its presence is known to correlate with an increase in all-cause mortality. 7 In addition to vaso-occlusion, chronic haemolysis is also a fundamental pathological process that occurs in SCA. Indeed some have suggested that SCA can be split into two subphenotypes based on the relative dominance of one or other of these processes in individual patients. [8] [9] [10] Pulmonary hypertension, a known complication in patients with the haemolytic subphenotype of SCD, is thought to be caused by vasculopathy related to the chronic nitric oxide depletion from continuing intravascular hemolysis. 11 Although the markers of SCN are known to predict the presence of pulmonary hypertension 12 it is still not clear if both conditions share the same pathological process. In children with SCA, significant associations have been found between proteinuria and the haemolysis markers of low haemoglobin (Hb) and high lactate dehydrogenase (LDH). 5, 13 Similar studies in adults, however, have not replicated this finding, although an association between low hemoglobin levels and hyperfiltration have been reported. [14] [15] More recently, Maier-Redelsperger et al utilised a marker of red cell survival derived from mature red blood cell hemoglobin (RBC-Hb) and reticulocyte haemoglobin (RET-Hb), and showed that the log (RBC-Hb/RET-Hb) was highly correlated with LDH, bilirubin and albuminuria. 16 In the present study we have carried out a retrospective investigation of the prevalence of albuminuria and hyperfiltration in a larger cohort of adults with SCD. We have also examined the associations between sickle cell nephropathy and markers of hemolysis, including RBC-Hb/RET-Hb to further elucidate the pathogenesis of this increasingly important complication.
Design and methods
The study group was drawn from a cohort of 484 patients with HbSS, HbS/β 0 or HbSC attending the specialist clinic at King's College Hospital, London, since January 2006.
Patients were excluded from the study group if they had a history of diabetes mellitus, HIV infection, malignancy or another cause of chronic kidney disease (CKD) or if they were on a blood transfusion programme. Seventeen patients were on ACE (angiotensin converting enzyme) inhibitor or (ARB) angiotensin II receptor blockers therapy; these patients were also excluded from the study. Since 2006, urinary albumin/creatinine ratio (ACR) has been a routine measurement for patients attending the specialist clinic. All patients were routinely genotyped for α thalassaemia using a PCR-based methodology on DNA extracted from peripheral blood. 17 Hematological and biochemical data were extracted from the electronic patient record (EPR) system into an anonymised database. Estimated glomerular filtration rates (eGFRs)
were calculated using the 4-point Modification of Diet in Renal Disease (MDRD) formula.
Bilirubin was always adjusted for uridine diphosphoglucuronate glucuronosyltransferase 1A (UGT1A ) genotype, a known genetic modifier of bilirubin levels in SCD. 18 A p value of <0.05 was considered significant. Data was manipulated and analysed using Excel 2007
(Microsoft, Seattle) and Prism 3 (GraphPad, San Diego, CA, USA). The regression analysis was performed in Stata 11 (Stata Corp). All analyses pooled all data from each individual allowing for dependency between multiple observations on the same individual using random effects models fitted either using generalised least squares or, when the dependent variable was either binary (logistic regression) or censored (interval regression),
by maximum likelihood. ACR was found to be skewed and consequently analysed in the logarithm which rendered it more normally distributed. ACR was also analysed as a dichotomous variable cut off at 4.5 mg/mmol (defined as microalbuminuria). Effects sizes were expressed as changes (or percentage changes or odds ratio (OR) depending on the dependent variable) per standard deviation (SD) of the dependent variable of interest. All analyses were repeated both with and without the presence of other covariates (age, sex, α-thalassemia and UGT1A genotypes, white blood cell (WBC) count and hydroxycarbamide treatment). In order to capture the complex nature of the relationships with age, the age pattern was fitted as a cubic spline on 4 degrees of freedom (i.e. using four evenly spaced nodes).
Results and discussion
After application of the various exclusion and inclusion criteria, the final study group In the HbSS/HbSβ 0 group, increasing age correlated with the degree of albuminuria (p=0.005 r 2 =0.06), and with the prevalence of microalbuminuria ( Figure 1A ). Table 1 describes the linear relationship of haemolytic markers with ACR and eGFR; a negative value (i.e. Hb, RBC-Hb/RET-Hb, and RBC-Hb) denotes an inverse trend. When analysed without controlling for co-variates the degree of albuminuria was significantly predicted by all the variables relating to haemolysis, including RBC-Hb/RET-Hb (Table 1a) . Bilirubin and LDH were the strongest predictors (p<0.00001% change/SD 57.7 and p<0.00001% change/SD 45.5, respectively). Reticulocyte count was the weakest predictor (p=0.02 % change/SD 11.0). RBC-Hb, calculated by subtracting reticulocyte Hb (absolute reticulocyte count x reticulocyte Hb) from total Hb, was a stronger negative predictor of albuminuria than Hb (p<0.00001 %change/SD -41.1 vs p=0.0005 %change/SD -17.8). When ACR was analysed as a dichotomous variable (≥4.5mg/mmol referred to as microalbuminuria) the associations persisted; LDH remained the strongest predictor (p<0.00001, OR/SD 0.72) and reticulocyte count remained the weakest (p=0.06, OR/SD 0.57) (Table 1a ). In the multivariate analysis the correlation with reticulocyte count was lost, while other correlations remained significant (Table 1a) . 185/260 (71%) of the HbSS/HbSβ 0 group had at least one eGFR of ≥ 140 ml/min/1.73m 2 during the study period. Overall, eGFR was found to be significantly negatively correlated with age (r 2 = 0.22 p < 0.0005) ( Figure 1C ) although it appears positively correlated in the under 25 age group. Reticulocyte count was the strongest predictor of eGFR when uncorrected (p<0.00001, absolute effect per SD 5.1) and when corrected for covariates (p<0.00001 absolute effect per SD 7.7) (Table 1b) . Bilirubin only became a significant predictor after controlling for covariates (p<0.01 effect per SD 5.1) (Table 1b) .
41/164 (26%) HbSC had at least one sample with an ACR ≥4.5 mg/mmol (i.e. microalbuminuria). There was no significant association between degree of albuminuria and age, although there was an increase in the prevalence of microalbuminuria in this group with age ( Figure 1A ). Only RBC-Hb was a significant predictor of degree of albuminuria without (p=0.004, % change/ SD -34.2%) and with (p<0.0001, % change/SD -53.7%)
controlling for co-variates (Table 2a ). Alpha genotype status was known in 130/164 (79%)
of HbSC patients, 41 (32%) had alpha trait (39 αα/α -and 2α-/α-) and the rest (89) had normal α genotype (αα/αα). The presence of alpha thalassaemia trait had no influence on the development of albuminuria in the HbSC population (p=0.2, 95%CI -0.18, 0.89).
39/164 patients (24%) had at least one eGFR of ≥ 140 ml/min/1.73m 2 during the study period. Estimated GFR was significantly associated with reticulocyte count in both simple and multiple regression analysis (Table 2b ) although less strongly than in the SCA population. This is likely to be explained by the more homogeneous HbSC population with less variation in hemolysis.
Sickle cell nephropathy (SCN) is an important cause of morbidity and mortality in patients with SCD. 19 It is characterised by hyperfiltration at a young age, followed by a gradual reduction in GFR and worsening proteinuria, in some cases culminating in end-stage renal failure, which itself has a markedly increased risk of death. 4 We have demonstrated a high prevalence of SCN amongst a UK sickle population, with a combined incidence of hyperfiltration (as defined by an eGFR of ≥140 ml/min/1.73 m 2 ) of 71%, and of microalbuminuria (ACR of ≥4.5 mg/mmol) of 37%, making SCN one of the most common complications of SCA.
We have also demonstrated associations between both degree and prevalence of albuminuria and all markers of increased hemolysis including the new parameter of red cell survival described by Maier-Redelsperger et al. 16 In addition, an association was found between hyperfiltration and high reticulocyte counts, another marker for hemolysis.
Co-inheritance of alpha thalassemia, has a protective effect against albuminuria in SCA patients with a negative association between number of deleted alpha-genes and the degree of albuminuria and prevalence of microalbuminuria. A previous study by Nebor et al.
showed that alpha thalassaemia was associated with a delayed age-of-onset of albuminuria in SCA patients but an association between albuminuria and LDH could not be shown.
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Levels of hemolysis vary amongst patients with SCA, and the existence of a sub-phenotype of patients with markedly increased hemolysis has been postulated. 8 Patients with high levels of hemolysis have increased mortality, and increased rates of specific sickle complications including pulmonary hypertension, priapism and leg ulcers. 21 Our data suggests that SCN is also associated with the haemolytic sub-phenotype of SCA. Asnani et al, however, suggest that higher rates of hemolysis were not associated with albuminuria in Jamaicans with SCD but this study analysed both HbSS and HbSC patients, who have quite different disease severity, as a group.
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There are several potential limitations to this study. There is the potential confounding between haemolytic and vaso-occlusive mechanisms of renal damage and the lack of a reliable measurement of vascular occlusion to control for. Further studies with larger cohorts are required to describe more accurately the association between haemolysis and SCN. As this study is clinic-based, there is also a risk of sampling bias towards patients who have more severe disease. Another limitation is the reliance on estimations of GFR by the MDRD formula. MDRD eGFR relies on measurements of serum creatinine. This molecule is maximally secreted by the proximal tubule in patients with SCA and is known to overestimate GFR at high ranges. However Haymann et al have measured GFR in a proportion of their patients with SCA using accurate radio-labelled isotope techniques. They found that eGFR using the MDRD formula was a robust predictor of hyperfiltration when compared to the actual GFR. 15 Although our data have confirmed the downward trend of eGFR and upward trend of ACR as patients age, the exact temporal and pathological relationship between these two factors has not been fully investigated in individual patients, and further prospective studies are needed. The use of angiotensin-converting enzyme (ACE) inhibiting medications has been shown to reduce levels of proteinuria in small-scale trials and may prove to be beneficial in delaying the onset of CKD. 23 In view of the seriousness of this complication, large-scale randomised controlled trials of therapies to halt progression of SCN are urgently required.
In conclusion, we have shown associations between raised haemolytic markers and the presence of both albuminuria and glomerular hyperfiltration in patients with the more severe form of SCD, HbSS and HbSβ 0 thalassemia. We have also demonstrated a protective effect of α -thalassemia against the onset of albuminuria, which is in keeping with the reduced haemolysis associated with this genotype. Our data emphasises the progressive nature of renal impairment in SCA. Clinically, raised markers of haemolysis may prove to be useful in identifying those at increased risk of developing sickle cell nephropathy.
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